Darmiyan has developed the first AI-powered software platform for early detection, monitoring, and stratification of Alzheimer's disease.
Darmiyan has raised $3.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.
Darmiyan's investors include Y Combinator, Amgen, Pegasus Tech Ventures, SkyDeck Berkeley, DHVC.
Darmiyan is headquartered in San Francisco, United States.
Darmiyan has developed the first AI-powered software platform for early detection, monitoring, and stratification of Alzheimer's disease.
Darmiyan is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Darmiyan — Funding & Investors." VCBacked, October 17, 2023, https://www.vcbacked.co/company/darmiyan. Accessed August 14, 2026.
VCBacked. (2023). Darmiyan — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/darmiyan
{{cite web |title=Darmiyan — Funding & Investors |url=https://www.vcbacked.co/company/darmiyan |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated